Not Tagged
natera
[]
our five presentations at #gi23 will highlight findings on the utility of signatera for #mrd assessment in colorectal (#crc), esophageal, gastric and anal cancers. read more in our latest press release. 
Transforming the management of cancer with #Signatera, the personalized test for molecular residual disease detection and recurrence monitoring.